hexobendine
This page covers all hexobendine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sodium channel alpha subunits; brain (Types I, II, III).
Targets
Sodium channel alpha subunits; brain (Types I, II, III)
Phase 2 pipeline (1)
- Ditrimin · Neuroscience
Ditrimin works by blocking sodium channels in the brain to modulate nerve impulses.
Patent intelligence
- hexobendine patent landscape — aggregated cliff calendar, attackable patents, originator estates